A Clinical Study Assessing Critical Errors, Training/Teaching Time, and Preference Attributes of the ELLIPTA® Dry Powder Inhaler, in Comparison to Combinations of Dry Powder Inhalers Used to Provide Triple Therapy, in Patients With Chronic Obstructive Pulmonary Disease
Clinical trial NCT02982187 · COMPLETED
Trial details
- NCT number
- NCT02982187
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-30
- Primary completion
- 2017-06-19
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.